Abby Lee Tower, M.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2141 N Dan Jones Rd, Avon, IN 46123 Phone: 317-943-3932 |
Mr. Brandon Soots, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5810 E County Road 100 N, Avon, IN 46123 Phone: 765-730-2619 |
Mrs. Jenica L Taber, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-217-3079 Fax: 317-217-3073 |
Say It Therapy Services, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1062 Park Ct, Avon, IN 46123 Phone: 630-742-6238 |
Mrs. Stacie L. Bryant, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 603 Port Drive, Avon, IN 46123 Phone: 317-272-8238 |
Lacey Jane Staton, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1335 Maria Ln, Avon, IN 46123 Phone: 317-965-0694 |
Mrs. Beth Ann Stone, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1006 Locust Ave, Batesville, IN 47006 Phone: 812-569-8465 Fax: 812-932-7771 |
Mrs. Elesha Sharp, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Lammers Pike, Batesville, IN 47006 Phone: 812-934-5090 |
Mr. Alan Ricky Hill, MACCCLSP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 321 Mitchell Ave, Batesville, IN 47006 Phone: 812-934-6624 Fax: 812-934-6122 |
Alicia Mae Holtkamp Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 958 Highway 46 E, Batesville, IN 47006 Phone: 812-934-2436 |
Evelyn Owens, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2221 John Williams Blvd, Bedford, IN 47421 Phone: 812-329-1284 |
Leana Michelle Massimini, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3710 Kenneth Simpson Ln, Bedford, IN 47421 Phone: 812-275-7006 |
Bedford Outpatient Therapy Specialists Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2137 16th St, Bedford, IN 47421 Phone: 812-275-5593 Fax: 812-275-5598 |
Bedford Outpatient Therapy Specialists Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2137 16th St, Bedford, IN 47421 Phone: 812-275-5593 Fax: 812-275-5598 |
Bree Breton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 278 Trogdon Ln, Bedford, IN 47421 Phone: 219-281-2279 |
Mrs. Grace Messersmith Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 501 N 17th Ave, Beech Grove, IN 46107 Phone: 317-786-2261 |
Ms. Julie Ann Weaver, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 919 Main St, Beech Grove, IN 46107 Phone: 317-413-9866 Fax: 317-786-1841 |
Anna Marie Goss, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 N 17th Ave, Beech Grove, IN 46107 Phone: 317-219-3889 Fax: 317-324-3965 |
Katherine Paige Keena Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1230 Timbrook Ln, Beech Grove, IN 46107 Phone: 260-615-1703 |
Daniel Fogerty, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 N Bell Trace Cir, Bloomington, IN 47408 Phone: 812-323-2858 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has acquired the U.S. marketing rights to the Timoptic product line from Merck & Co., Inc. Timoptic (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
One third of United States Armed Forces Veterans store at least one firearm loaded with ammunition and unlocked, according to a new study published in the American Journal of Preventive Medicine that reports on the first survey of a nationally representative sample of this group regarding storage practices.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
The Trump administration is considering a policy change that might discourage immigrants who are seeking permanent residency from using government-supported health care, a scenario that is alarming some doctors, hospitals and patient advocates.
When injected into rats' hearts soon after a heart attack, stem cells taken from human umbilical cord blood (HUCB) greatly reduced the size of heart damage and restored pumping function to near normal. This improvement occurred without the need for drugs to prevent the rats' immune system from rejecting the human cells.
› Verified 5 days ago